Risk factors of ovarian cancer: family history, obesity and oral contraceptive use
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.046Keywords
ovarian cancer, risk factors, obesity, oral contraceptive, BRCA, family historyAbstract
Introduction and purpose:
Ovarian cancer (OC) takes the 7th place among most common female malignancies worldwide. There are almost 240 thousand of new cases diagnosed each year and the number is constantly growing. Defining risk factors of OC is essential to provide good education among women and predict this malignancy better. The aim of this review is to analyze the current data on risk factors of OC concentrating on family history, obesity andoral contraceptives use.
Material and method:
This review was based on articles from 2010 to 2020 collected in PubMed and concerning the impact of several risk factors on developing OC.
Results:
The best described risk factor of OC is genetics and family history. 75% or hereditary OCs are associated to BRCA genes mutations, especially BRCA1. Other mutations increasing the risk of OC are MSH2 and MLH1 genes mutations. Diverse risk factors correlate with different histological subtypes of OC. Obesity increases the levels of estrogens, androgens and leptin, which may promote the proliferation of ovarian epithelial cells. Using oral contraceptives is related to 20% decreased risk of OC for each 5 years of use.
Conclusions:
BRCA1/2, MSH2 and MLH1 mutations and obesity are well-defined risk factors of ovarian cancer. The first-choice risk-reducing procedure among BRCA carriers is bilateral salpingo-oophorectomy. On the contrary, using oral contraceptives results in decreased risk of OC. Promoting knowledge about OC risk factors among women and healthcare professionals is crucial in order to reduce the number of ovarian cancer.
References
Dinca AL, Bîrla RD, Dinca VG, Marica C, Panaitescu E, Constantinoiu S. Prognostic Factors in Advanced Ovarian Cancer - A Clinical Trial. Chirurgia (Bucur). 2020;115(1):50–62. doi: 10.21614/chirurgia.115.1.50
Reid, B. M., Permuth, J. B., & Sellers, T. A. (2017). Epidemiology of ovarian cancer: a review. Cancer biology & medicine, 14(1), 9–32. https://doi.org/10.20892/j.issn.2095-3941.2016.0084
Mallen, A. R., Townsend, M. K., & Tworoger, S. S. (2018). Risk Factors for Ovarian Carcinoma. Hematology/Oncology Clinics of North America. doi:10.1016/j.hoc.2018.07.002
Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3-14. doi:10.1016/j.bpobgyn.2016.08.006
Kari L. Ring, Christine Garcia, Martha H. Thomas, Susan C. Modesitt, Current and future role of genetic screening in gynecologic malignancies, American Journal of Obstetrics and Gynecology, Volume 217, Issue 5, 2017, Pages 512-521, https://doi.org/10.1016/j.ajog.2017.04.011.
Adrianne R. Mallen, Mary K. Townsend, Shelley S. Tworoger, Risk Factors for Ovarian Carcinoma, Hematology/Oncology Clinics of North America, Volume 32, Issue 6, 2018, Pages 891-902, https://doi.org/10.1016/j.hoc.2018.07.002.
Tschernichovsky R, Goodman A. Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act. Oncologist. 2017;22(4):450-459. doi:10.1634/theoncologist.2016-0444
Marchetti C, De Felice F, Palaia I, et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014;14:150. Published 2014 Dec 12. doi:10.1186/s12905-014-0150-5
Wentzensen N, Poole EM, Trabert B, et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016;34(24):2888-2898. doi:10.1200/JCO.2016.66.8178
Tworoger SS, Huang T. Obesity and Ovarian Cancer. Recent Results Cancer Res. 2016;208:155-176. doi:10.1007/978-3-319-42542-9_9
Dunneram Y, Greenwood DC, Cade JE. Diet, menopause and the risk of ovarian, endometrial and breast cancer. Proc Nutr Soc. 2019;78(3):438-448. doi:10.1017/S0029665118002884
Foong KW, Bolton H. Obesity and ovarian cancer risk: A systematic review. Post Reprod Health. 2017;23(4):183-198. doi:10.1177/2053369117709225
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2012) Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies. PLOS Medicine 9(4): e1001200. https://doi.org/10.1371/journal.pmed.1001200
Nagle CM, Dixon SC, Jensen A, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113(5):817-826. doi:10.1038/bjc.2015.245
Au-Yeung G, Webb PM, DeFazio A, Fereday S, Bressel M, Mileshkin L. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). Gynecol Oncol. 2014;133(1):16-22. doi:10.1016/j.ygyno.2014.01.030
Moorman PG, Havrilesky LJ, Gierisch JM, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31(33):4188-4198. doi:10.1200/JCO.2013.48.9021
Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P et al (2010) Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer 46(12):2275–2284
Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. Am J Obstet Gynecol. 2017;216(6):580.e1-580.e9. doi:10.1016/j.ajog.2017.02.002
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 801
Number of citations: 0
